Final overall survival (OS) results from the INAVO120 trial (NCT04191499) confirmed that the addition of inavolisib (Itovebi) ...

Demographic differences in expected NT-proBNP (N-terminal pro-B-type natriuretic peptide) concentration are not well established ... Past medical history, including a diagnosis of diabetes (type 1 or ...

SEER, Surveillance, Epidemiology and End Results. Of the 604 women, 58 reported having a physician-diagnosis of type 2 diabetes. We analyzed postdiagnosis fasting C-peptide in relation to all causes ...

Diabetes is a leading global health and economic challenge, affecting over 800 million people worldwide, with over 80% ...

This limits its clinical usefulness in inpatient settings. The findings published online in Diabetes Technology & Therapeutics indicate that C-peptide levels do not strongly predict the future need ...

Living with type 1 diabetes is a lifelong challenge, but for women, the disease can pose additional complications tied to hormonal changes throughout their lives. Experts say education and ...

Telemedicine helped increase access to endocrinology care for adults with type 2 diabetes and atherosclerotic cardiovascular disease living in rural areas, but several disparities remain ...

One of the things we're planning on talking about in D.C. is renewal of the funding for the Special Diabetes Program.” ...

Type 2 diabetes is not reversible, but it can go into remission, meaning your blood sugar levels return to normal without medication for at least three months. Some people can achieve this by ...

Elevated C-reactive protein (CRP) levels have previously been described before the onset of type 2 diabetes and gestational diabetes. We hypothesized that inflammation, as reflected by elevated ...

The number of Indigenous Australians with diabetes has risen almost 40 per cent in a decade, new data shows, with unprecedented levels of pediatric diabetes casting the next generation into danger.